Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Trials & Filings in Brief: Nov. 13, 2013 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Trials & Filings

Trials & Filings in Brief: Nov. 13, 2013

Discovery Labs, Fibrogen, Pluristem, RXi, Tekmira, Vivus, Zysis

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Preclinical
Tekmira posts Ebola, Marburg delay-to-treatment results . . . read more

Phase II
Discovery Labs cleared to begin IIa/b Aerosurf trial . . . read more

Fibrogen presents CKD-ESRD hemoglobin correction data . . . read more

Pluristem cleared by MFDS for IC trial . . . read more

RXi begins study in scar correction . . . read more

Filings
Vivus’ Qysmia receives two new patents . . . read more

Zysis gets LAO Aripiprazole patent . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics